Research groups in modern biotechnology in Brazil
a review of the foundations of its STI policy
DOI:
https://doi.org/10.52712/issn.1850-0013-670Keywords:
biotechnology, research groups, STI policy, BrazilAbstract
Based on the analysis of the CNPq Research Group Directory, this article analyzes the research capabilities in modern biotechnology in Brazil. This is a first step to build an accurate method to identify the research groups that develop activities in the frontier areas of biotechnology. This paper aims at offering accurate information about the research capabilities in this area, which can be used as a tool for critically reviewing the foundations of the current policies devoted to support biotechnological activities. This work was done through a key word searching methodology in the CNPq database and sustains the fact that the number of research groups in modern biotechnology is significantly smaller than the number identified in the official policy documents. However, it is not the purpose of this article to find mistakes in those documents, but to provide arguments about the relevance of building reliable indicators as the basis of policy formulation. Moreover, this article characterizes the “cognitive map” of the research lines in modern biotechnology in Brazil. Finally, it discusses the specific features of the research capabilities pattern of territorial agglomeration.
Downloads
References
ARUNDEL, A. (2003): “Biotechnology Indicators and Public Policy”, OECD Science, Technology and Industry Working Papers, 2003/5, OECD Publishing.
ARUNDEL, A.; VAN BEUZEKOM, B. y GILLESPIE, I. (2007): “Defining biotechnology - carefully”. TRENDS in Biotechnology,vol. 25, nº 8, pp. 331-332.
BIANCHI, C. (2009): “Área de Biotecnologia: Análise do Programa de Subvenção - MCT - FINEP”, Nota Técnica No 2., Rio de Janeiro, Observatório de Políticas de Inovação e Produção no Brasil, RedeSist, Instituto de Economia, UFRJ.
BRASIL, GOVERNO FEDERAL (2007): “Política de Desenvolvimento da Biotecnologia”.
BRASIL, GOVERNO FEDERAL (2008): “Política de Desenvolvimento Produtivo”.
BRASIL, MINISTÉRIO DE CIÊNCIA E TECNOLOGIA (MCT) (2007): “Plano de Ação 2007-2010 da Ciência, Tecnologia e Inovação para o Desenvolvimento”.
BRASIL, MINISTÉRIO DE DESENVOLVIMENTO, INDÚSTRIA E COMÉRCIO EXTERIOR (MDIC) (2003): “Diretrizes de Política Industrial, Tecnológica e de Comércio Exterior”.
BRASIL. MINISTÉRIO DA SAÚDE. (MS) (2006): “Política Nacional de Ciência Tecnologia e Inovação em Saúde”, Brasília, Ministério da Saúde.
CASSIOLATO, J.; ZUCOLOTO, G.; RAPINI, M. y ANTUNES, S. (2009): “The recent evolution of the Biotech local innovation system of Minas Gerais: university, local firms and transnational corporations”, UNIDEV Project Working paper.
COLLINS, H. (1974): “The TEA Set: Tacit Knowledge and Scientific Networks”, Science Studies, vol. 4, pp. 65-86.
CORTRIGHT, J. y MAYER, H. (2002): Signs of Life: The Growth of Biotechnology Centers in the U.S., The Brookings Institution Center on Urban and Metropolitan Policy.
COOKE, P. (2001): “Biotechnology Clusters in the U.K.: Lessons from Localisation in the Commercialisation of Science”, Small Business Economics, vol. 17, pp. 43-59.
FONSECA, M. da G. (2009): “Documento Setorial: Biotecnologia”, Projeto Perspectivas do Investimento no Brasil. Sistema Produtivo: Baseados em ciência. BNDES, UFRJ y Unicamp.
GADELHA, C. (1990): “Biotecnologia em Saúde: um estudo da mudança tecnológica na indústria farmacêutica e das perspectivas de seu desenvolvimento no Brasil”, Master dissertation, IE - UNICAMP, Campinas.
GERTLER, M. y VINDORAI, T. (2009): “Life Sciences and Regional Innovation: One Path or Many?”, European Planning Studies, vol. 17, nº 2, pp 235-261.
GIBBONS, M.; LIMOGES, C.; NOWOTNY, H.; SCHWARTZMAN, S.; SCOTT, P. y TROW, M. (1997): La nueva producción de conocimiento. La dinámica de la ciencia y la investigación en las sociedades contemporáneas,Barcelona, Ediciones Pomares- Corredor S.A.
JORNAL DA CIÊNCIA (2010): “Ciência rural turbina publicação no país”, 28 de Julho de 2010. Disponible em: http://www.jornaldaciencia.org.br/Detalhe.jsp?id=72446.
JUDICE, V. y VEDOVELLO, C. (2007): “Biotechnology innovation system in Brazil: an exploratory study”, Research Paper 13/07, BRICS, REDESIST, IE, UFRJ.
LASTRES, H.; CASSIOLATO, J. y ARROIO, A. (2005): “Sistemas de inovação e desenvolvimento: mitos e realidades da economia do conhecimento”, em H. M. M., Lastres; J. E. Cassiolato y A. Arroio (orgs.): Conhecimento, sistemas de inovação e desenvolvimento, Rio de Janeiro, Editora da UFRJ e Contraponto.
MENDONÇA, M. A. y FREITAS, R. (2008): “Biotecnologia: perfil dos grupos de pesquisa no Brasil”, Apresentado em: XLVI Congresso da Sociedade Brasileira de Economia, Administração e Sociologia Rural, Rio Branco.
MILLER, H. (2007): “Biotech’s defining moments”, Trends Biotechnology,vol. 25, pp. 56-59.
ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD) (2005): “A framework for biotechnology statistics”, OECD.
ORSENIGO, L. (1989): The emergence of biotechnology,Londres, Pinter Publishers.
PISANO, G. (2006): Science Business. The promise, the reality and the future of biotech, Boston, Harvard University Press.
RAPINI, M. (2007): “Interação Universidade-Empresa no Brasil: Evidências do Diretório dos Grupos de Pesquisa do CNPq”, Estudos Econômicos,vol. 37, nº 1, pp. 211-233.
REDESIST (2010a): “Análise das políticas de APLs no Brasil”, Seminário de pesquisa 18 a 21 de maio, Rio de Janeiro.
REDESIST (2010b): “Elementos para o desenvolvimento de uma tipologia de APLs - GTP-APL/MDIC”, Seminário Rio de Janeiro, 4 a 6 de Agosto de 2010.
SUTZ, J.; BIANCO, M.; BIANCHI, C.; BIELLI, A.; BUTI, A.; GUERRA, G.; HEIN, P.; IBARRA, R.; MUJICA, A.; ROCCA, P. y ZAMALVIDE, M. (2003): Grupos de investigación en la Universidad de la República,Montevideo, CSIC.
ZELLER, C. (2001): “Clustering Biotech: A Recipe for Success? Spatial Patterns of Growth of Biotechnology in Munich, Rhineland and Hamburg”, Small Business Economics,vol. 17, pp. 123-141.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 CC Attribution 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
All CTS's issues and academic articles are under a CC-BY license.
Since 2007, CTS has provided open and free access to all its contents, including the complete archive of its quarterly edition and the different products presented in its electronic platform. This decision is based on the belief that offering free access to published materials helps to build a greater and better exchange of knowledge.
In turn, for the quarterly edition, CTS allows institutional and thematic repositories, as well as personal web pages, to self-archive articles in their post-print or editorial version, immediately after the publication of the final version of each issue and under the condition that a link to the original source will be incorporated into the self-archive.
